Xenon Pharmaceuticals Stock Forecast
NASDAQ: XENEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
XENE analyst consensus
Consensus (19 analysts)
strong_buy
Avg. price target
$73.37+102.90%
- Strong buy 3
- Buy 15
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 19 Wall Street analysts covering Xenon Pharmaceuticals (2026-10-07), 18 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $73.37, with a high estimate of $97.00 and a low estimate of $46.00. The average target implies upside of 102.9% from the current price of $36.16.
The spread between the highest and lowest targets is 110.9%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for XENE.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 16% |
| Buy | 15 | 79% |
| Hold | 1 | 5% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $46.00 | +27.21% |
| Average target | $73.37 | +102.90% |
| High target | $97.00 | +168.25% |